Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | |
|---|---|---|---|---|---|
| Operating cash flow (direct method) | |||||
| Cash income from operating activities | 6.81%460.38M | 0.19%431.01M | 9.05%430.21M | 19.76%394.51M | 329.41M |
| Revenue from customers | 6.81%460.29M | 0.35%430.93M | 9.21%429.42M | 20.68%393.2M | --325.83M |
| Income from government grants | 28.17%91K | -91.00%71K | -39.72%789K | -63.49%1.31M | --3.59M |
| Cash paid | -7.69%-422.07M | -1.01%-391.93M | -10.57%-388M | -20.86%-350.91M | -290.34M |
| Payments to suppliers for goods and services | -7.69%-422.07M | -1.01%-391.93M | -10.57%-388M | -20.86%-350.91M | ---290.34M |
| Direct interest paid | -4.37%-6.63M | -13.02%-6.36M | -78.48%-5.62M | 2.63%-3.15M | ---3.24M |
| Direct tax refund paid | 36.04%-3.95M | -50.59%-6.17M | 29.91%-4.1M | 45.70%-5.85M | ---10.77M |
| Operating cash flow | 4.45%27.73M | -18.29%26.55M | -6.10%32.49M | 38.01%34.6M | --25.07M |
| Investing cash flow | |||||
| Cash flow from continuing investing activities | 37.94%-7.16M | 28.82%-11.53M | 59.66%-16.2M | -41.53%-40.17M | -28.38M |
| Net PPE purchase and sale | 37.94%-7.16M | 28.82%-11.53M | 46.08%-16.2M | -207.89%-30.05M | ---9.76M |
| Net business purchase and sale | ---- | ---- | ---- | 93.62%-1.19M | ---18.62M |
| Net other investing changes | ---- | ---- | ---- | ---8.93M | ---- |
| Cash from discontinued investing activities | |||||
| Investing cash flow | 37.94%-7.16M | 28.82%-11.53M | 59.66%-16.2M | -41.53%-40.17M | ---28.38M |
| Financing cash flow | |||||
| Cash flow from continuing financing activities | -16.27%-22.09M | -53.34%-19M | -13.13%-12.39M | -129.54%-10.95M | 37.08M |
| Net issuance payments of debt | -147.25%-539K | 41.87%-218K | -150.61%-375K | 102.70%741K | ---27.42M |
| Net common stock issuance | ---- | ---- | ---- | ---- | --122.66M |
| Cash dividends paid | -18.19%-15.87M | -83.33%-13.43M | 0.00%-7.32M | 87.41%-7.32M | ---58.16M |
| Net other financing activities | 46.93%-5.68M | -128.26%-10.71M | -7.37%-4.69M | ---4.37M | ---- |
| Cash from discontinued financing activities | |||||
| Financing cash flow | -16.27%-22.09M | -53.34%-19M | -13.13%-12.39M | -129.54%-10.95M | --37.08M |
| Net cash flow | |||||
| Beginning cash position | -11.16%32.35M | 13.83%36.41M | -34.71%31.99M | 221.36%48.99M | --15.24M |
| Current changes in cash | 61.87%-1.52M | -202.36%-3.99M | 123.56%3.89M | -148.94%-16.53M | --33.77M |
| Effect of exchange rate changes | 107.69%6K | -114.72%-78K | 210.88%530K | -1,978.26%-478K | ---23K |
| End cash Position | -4.68%30.83M | -11.16%32.35M | 13.83%36.41M | -34.71%31.99M | --48.99M |
| Free cash from | 37.02%20.57M | -7.80%15.01M | 257.99%16.29M | -70.29%4.55M | --15.31M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |